A total of 4,788 specimens from 242 screened and phenotyped adults^[@R1]--[@R2]^ (129 males, 113 females) were available for this study, representing the majority of the target HMP cohort of 300 individuals. Adult subjects lacking evidence of disease were recruited based on a lengthy list of exclusion criteria; we will refer to them here as "healthy," as defined by the consortium clinical sampling criteria^[@R2]^. Women were sampled at 18 body habitats, men at 15 (excluding three vaginal sites), distributed among five major body areas. Nine specimens were collected from the oral cavity and oropharynx: saliva; buccal mucosa (cheek), keratinized gingiva (gums), palate, tonsils, throat, and tongue soft tissues; and supra- and subgingival dental plaque (tooth biofilm above and below the gum). Four skin specimens were collected from the two retroauricular creases (behind each ear) and the two antecubital fossae (inner elbows), and one specimen for the anterior nares (nostrils). A self-collected stool specimen represented the microbiota of the lower gastrointestinal tract, and three vaginal specimens were collected from the vaginal introitus, midpoint, and posterior fornix. In order to evaluate within-subject stability of the microbiome, 131 individuals in these data were sampled at an additional time point (mean 219 sd. 69 days after first sampling, range 35--404 days). After quality control, these specimens were used for 16S rRNA gene analysis via 454 pyrosequencing (abbreviated henceforth as 16S profiling, mean 5,408 sd. 4,605 filtered sequences/sample); to assess function, 681 samples were sequenced using paired-end Illumina shotgun metagenomic reads (mean 2.9Gb sd. 2.1 per sample)^[@R1]^. More details on data generation are provided in related HMP publications^[@R1]--[@R2]^ and in [Supplemental Methods](#SD1){ref-type="supplementary-material"}.

Microbial diversity of healthy humans {#S1}
=====================================

The diversity of microbes within a given body habitat can be defined as the number and abundance distribution of distinct types of organisms, which has been linked to several human diseases: low diversity in the gut to obesity and inflammatory bowel disease^[@R3]--[@R4]^, for example, and high diversity in the vagina to bacterial vaginosis^[@R5]^. For this large study involving microbiome samples collected from healthy volunteers at two distinct geographic locations in the United States, we have defined the microbial communities at each body habitat, encountering 81--99% of predicted genera and saturating the range of overall community configurations ([Fig. 1](#F1){ref-type="fig"}, [Supp. Fig. 1](#SD1){ref-type="supplementary-material"}, [Supp. Table 1](#SD3){ref-type="supplementary-material"}, see also [Fig. 4](#F4){ref-type="fig"}). Oral and stool communities were especially diverse in terms of community membership, expanding prior observations^[@R6]^, and vaginal sites harbored particularly simple communities ([Fig. 1A](#F1){ref-type="fig"}). This study established that these patterns of alpha diversity (within samples) differed markedly from comparisons between samples from the same habitat among subjects (beta diversity, [Fig. 1B](#F1){ref-type="fig"}). For example, the saliva had among the highest median alpha diversities of Operational Taxonomic Units (OTUs, roughly species level classification, see <http://hmpdacc.org/HMQCP>), but one of the lowest beta diversities - so although each individual's saliva was ecologically rich, members of the population shared similar organisms. Conversely, the antecubital fossae (skin) had the highest beta diversity but were intermediate in alpha diversity. The vagina had the lowest alpha diversity, with quite low beta diversity at the genus level but very high among OTUs due to the presence of distinct *Lactobacillus* spp. ([Fig. 1B](#F1){ref-type="fig"}). The primary patterns of variation in community structure followed the major body habitat groups (oral, skin, gut, and vaginal), defining as a result the complete range of population-wide between-subject variation in human microbiome habitats ([Fig. 1C](#F1){ref-type="fig"}). Within-subject variation over time was consistently lower than between-subject variation, both in organismal composition and in metabolic function ([Fig. 1D](#F1){ref-type="fig"}). The uniqueness of each individual's microbial community thus appear to be stable over time (relative to the population as a whole), which may be another feature of the human microbiome specifically associated with health.

No taxa were observed to be universally present among all body habitats and individuals at the sequencing depth employed here, unlike several pathways ([Fig. 2](#F2){ref-type="fig"} and [Supp. Fig. 2](#SD1){ref-type="supplementary-material"}, see below), although several clades demonstrated broad prevalence and relatively abundant carriage patterns^[@R7]--[@R9]^. Instead, as suggested by individually focused studies^[@R3]--[@R4],[@R6],[@R10]--[@R11]^, each body habitat in almost every subject was characterized by one or a few signature taxa making up the plurality of the community ([Fig. 3](#F3){ref-type="fig"}). Signature clades at the genus level formed on average anywhere from 17% to 84% of their respective body habitats, completely absent in some communities (0% at this level of detection) and representing the entire population (100%) in others. Strikingly, less dominant taxa were also highly personalized, both among individuals and body habitats; in the oral cavity, for example, most habitats are dominated by *Streptococcus*, but these are followed in abundance by *Haemophilus* in the buccal mucosa, *Actinomyces* in the supragingival plaque, and *Prevotella* in the immediately adjacent (but low oxygen) subgingival plaque^[@R12]^.

Additional taxonomic detail of the human microbiome was provided by identifying unique marker sequences in metagenomic data^[@R13]^ ([Fig. 3A](#F3){ref-type="fig"}) to complement 16S profiling ([Fig. 3B](#F3){ref-type="fig"}). These two profiles were typically in close agreement ([Supp. Fig. 3](#SD1){ref-type="supplementary-material"}), with the former in some cases offering more specific information on members of signature genera differentially present within habitats (e.g. vaginal *Prevotella amnii* and gut *P. copri*) or among individuals (e.g. vaginal *Lactobacillus* spp.) One application of this specificity was to confirm the absence of NIAID class A--C pathogens above 0.1% abundance (aside from *S. aureus* and *E. coli*) from the healthy microbiome, but the near-ubiquity and broad distribution of opportunistic "pathogens" as defined by PATRIC^[@R14]^. Canonical pathogens including *Vibrio cholerae*, *Mycobacterium avium*, *Campylobacter jejuni*, and *Salmonella enterica* were not detected at this level of sensitivity. *Helicobacter pylori* was found in only two gut samples, both at \<0.01%, and *E. coli* was present at \>0.1% abundance in 15% of stool microbiomes (\>0% abundance in 61%). Similar species level observations were obtained for a small subset of stool samples with 454 pyrosequencing metagenomics data using PhylOTU^[@R15]--[@R16]^. In total 56 of 327 PATRIC "pathogens" were detected in the healthy microbiome (at \>1% prevalence of \>0.1% abundance, [Supp. Table 2](#SD4){ref-type="supplementary-material"}), all opportunistic and, strikingly, typically prevalent both among hosts and habitats. The latter is in contrast to many of the most abundant signature taxa, which were usually more habitat-specific and variable among hosts ([Fig. 3A--B](#F3){ref-type="fig"}). This overall absence of particularly detrimental microbes supports the hypothesis that even given this cohort's high diversity, the microbiota tend to occupy a range of configurations in health distinct from many of the disease perturbations studied to date^[@R4],[@R17]^.

Carriage of specific microbes {#S2}
=============================

Inter-individual variation in the microbiome proved to be specific, functionally relevant, and personalized. One example of this is illustrated by the *Streptococcus* spp. of the oral cavity. The genus dominates the oropharynx^[@R18]^, with different species abundant within each sampled body habitat (see <http://hmpdacc.org/HMSMCP>) and, even at the species level, striking differences in carriage within each habitat among individuals ([Fig. 4A](#F4){ref-type="fig"}). As the ratio of pan- to core-genomes is high in many human-associated microbes^[@R19]^, this variation in abundance could be due to selective pressures acting on pathways differentially present among *Streptococcus* species or strains ([Fig. 4B](#F4){ref-type="fig"}). Indeed, we observed extensive strain-level genomic variation within microbial species in this population, enriched for host-specific structural variants around genomic islands ([Fig. 4C](#F4){ref-type="fig"}). Even with respect to the single *Streptococcus mitis* strain B6, gene losses associated with these events were common, for example differentially eliminating *S. mitis* carriage of the V-type ATPase or choline binding proteins cbp6 and cbp12 among subsets of the host population ([Fig. 4D](#F4){ref-type="fig"}). These losses were easily observable by comparison to reference isolate genomes, and these initial findings suggest that microbial strain- and host-specific gene gains and polymorphisms may be similarly ubiquitous.

Other examples of functionally relevant inter-individual variation at the species and strain levels occurred throughout the microbiome. In the gut, *Bacteroides fragilis* has been shown to prime T cell responses in animal models via the capsular polysaccharides PSA^[@R20]^, and in the HMP stool samples this taxon was carried at a level of at least 0.1% in 16% of samples (over 1% abundance in 3%). *B. thetaiotaomicron* has been studied for its effect on host gastrointestinal metabolism^[@R21]^ and was likewise common at 46% prevalence. On the skin, *Staphylococcus aureus*, of particular interest as the cause of methicillin-resistant *S. aureus* (MRSA) infections, had 29% nasal and 4% skin carriage rates, roughly as expected^[@R22]^. Close phylogenetic relatives such as *S. epidermidis* (itself considered commensal) were, in contrast, universal on the skin and present in 93% of nares samples, and at the opposite extreme *Pseudomonas aeruginosa* (a representative gram negative skin pathogen) was completely absent from both body habitats (0% at this level of detection). These and the data above suggest that the carriage pattern of some species in the human microbiome may be analogous to genetic traits, where recessive alleles of modest risk are maintained in a population. In the case of the human microbiome, high-risk pathogens remain absent, while species that pose a modest degree of risk also appear to be stably maintained in this ecological niche.

Finally, microorganisms within and among body habitats exhibited relationships suggestive of driving physical factors such as oxygen, moisture and pH, host immunological factors, and microbial interactions such as mutualism or competition^[@R23]^ ([Supp. Fig. 4](#SD1){ref-type="supplementary-material"}). Both overall community similarity and microbial co-occurrence and co-exclusion across the human microbiome grouped the 18 body habitats together into four clusters corresponding to the five target body areas ([Supp. Fig. 4A--B](#SD1){ref-type="supplementary-material"}). There was little distinction among different vaginal sites, with *Lactobacillus* spp. dominating all three and correlating in abundance. However, *Lactobacillus* varied inversely with the Actinobacteria and Bacteroidetes (see [Supp. Fig. 4C](#SD1){ref-type="supplementary-material"} and [Fig. 2](#F2){ref-type="fig"}--[3](#F3){ref-type="fig"}), as also observed in the cohort of Ravel et al^[@R11]^. Gut microbiota relationships primarily comprised inverse associations with the *Bacteroides*, which ranged from dominant in some subjects to a minority in others who carried a greater diversity of Firmicutes. A similar progression was evident in the skin communities, dominated by one of *Staphylococcus* (phylum Firmicutes), *Propionibacterium*, or *Corynebacterium* (both phylum Actinobacteria), with a continuum of oral organisms (e.g. *Streptococcus*) appearing in nares communities ([Supp. Fig. 4C](#SD1){ref-type="supplementary-material"}). These observations suggest that microbial community structure in these individuals may sometimes occupy discrete configurations and under other circumstances vary continuously, a topic addressed in more detail by several HMP investigations^[@R7],[@R24]--[@R25]^. An individual's location within such configurations is indicative of current microbial carriage (including pathogens) and of the community's ability to resist future pathogen acquisition or dysbiosis; it may thus prove to be associated with disease susceptibility or other phenotypic characteristics.

Microbiome metabolism and function {#S3}
==================================

As the first study to include both marker gene and metagenomic data across body habitats from a large human population, we additionally assessed the ecology of microbial metabolic and functional pathways in these communities. We reconstructed the relative abundances of pathways in community metagenomes^[@R26]^, which were much more constant and evenly diverse than were organismal abundances ([Fig. 2B](#F2){ref-type="fig"}, see also [Fig. 1](#F1){ref-type="fig"}), confirming this as an ecological property of the entire human microbiome^[@R3]^. We were likewise able to determine for the first time that taxonomic and functional alpha diversity across microbial communities significantly correlate (Spearman of inverse Simpson's r=0.60, p=3.6e-67, n=661), the latter within a more proscribed range of community configurations ([Supp. Fig. 5](#SD1){ref-type="supplementary-material"}).

Unlike microbial taxa, several pathways were ubiquitous among individuals and body habitats. The most abundant of these "core" pathways include the ribosome and translational machinery, nucleotide charging and ATP synthesis, and glycolysis, and reflect the basics of host-associated microbial life. Also in contrast to taxa, few pathways were highly variable among subjects within any body habitat; exceptions included the Sec (orally, sd. 0.0052, mean oral sd. 0.0011 sd. 0.0016) and Tat (globally, sd 0.0055, mean global sd. 0.0023 sd. 0.0033) secretion systems, indicating a high degree of host-microbe and microbe-microbe interactions in the healthy human microbiota. This high variability was particularly present in the oral cavity, for phosphate, mono- and di-saccharide, and amino acid transport in the mucosa, as well as LPS biosynthesis and spermidine/putrescine synthesis and transport on the plaque and tongue (<http://hmpdacc.org/HMMRC>). The stability and high metagenomic abundance of this housekeeping "core" contrasts with the greater variability and lower abundance of niche-specific functionality in rare but consistently present pathways, e.g. spermidine biosynthesis, methionine degradation, and hydrogen sulfide production, all examples highly prevalent in gastrointestinal body sites (nonzero in \>92% of samples) but at very low abundance (median rel. abd. \<0.0052). This "long tail" of low-abundance genes and pathways also likely encodes much of the uncharacterized biomolecular function and metabolism of these metagenomes, the expression levels of which remain to be explored in future metatranscriptomic studies.

Protein families showed diversity and prevalence trends similar to those of full pathways, ranging from maxima of only \~16,000 unique families per community in the vagina to almost 400,000 in the oral cavity ([Fig. 1A--B](#F1){ref-type="fig"}, <http://hmpdacc.org/HMGI>). A striking fraction of these families were indeed functionally uncharacterized, including those detected by read mapping, with a minimum in the oral cavity (mean 58% sd. 6.8%) and maximum in the nares (mean 77% sd. 11%). Likewise, many genes annotated from assemblies could not be assigned a metabolic function, with a minimum in the vagina (mean 78% sd. 3.4%) and maximum in the gut (mean 86% sd. 0.9%). The latter range did not differ substantially by body habitat and is in close agreement with previous comprehensive gene catalogs of the gut metagenome^[@R4]^. Taken together with the microbial variation observed above throughout the human microbiome, functional variation among individuals might indicate pathways of particular importance in maintaining community structure in the face of personalized immune, environmental, or dietary exposures among these subjects. Determining the functions of uncharacterized core and variable protein families will be especially essential in understanding the microbiota's role in health and disease.

Correlations with host phenotype {#S4}
================================

We finally examined relationships associating both clades and metabolism in the microbiota with host properties such as age, gender, BMI, and other available clinical metadata ([Fig. 5](#F5){ref-type="fig"}; [Supp. Table 3](#SD5){ref-type="supplementary-material"}). Using a sparse multivariate model, 960 microbial, enzymatic, or pathway abundances were significantly associated with one or more of 15 subject phenotype and sample metadata features. A wide variety of taxa, gene families, and metabolic pathways were differentially distributed with subject ethnicity at every body habitat ([Fig. 5A](#F5){ref-type="fig"}), representing the phenotype with the greatest number 266 at FDR q\<0.2) of total associations with the microbiome. Vaginal pH has also been observed to correlate with microbiome composition^[@R11]^, and we detected in this population both the expected reduction in *Lactobacillus* at high pH and a corresponding increase in metabolic diversity ([Fig. 5B](#F5){ref-type="fig"}). Intriguingly, and not previously observed, subject age was most associated with a collection of highly differential metagenomically encoded pathways on the skin ([Fig. 5C](#F5){ref-type="fig"}), as well as shifts in skin clades including retroauricular Firmicutes (p=1.0e-4, q=0.033). The examples of associations with ethnicity and vaginal pH are among the strongest associations with the microbiome, however, and most correlates (e.g. with subject BMI, [Fig. 5D](#F5){ref-type="fig"}) are more representatively modest. This lower degree of correlation held for most available biometrics (gender, temperature, blood pressure, etc.), with even the most significant associations possessing generally low effect sizes and considerable unexplained variance. We conclude that most variation in the human microbiome is not well-explained by these phenotypic metadata, and other potentially important factors such as short- and long-term diet, daily cycles, founder effects such as mode of delivery, and host genetics should be considered in future analyses.

Conclusions {#S5}
===========

This extensive sampling of the human microbiome across many subjects and body habitats provides an initial characterization of the normal microbiota of healthy adults in a Western population. The large sample size and consistent sampling of many sites from the same individuals allows for the first time an understanding of the relationships among microbes, and between the microbiome and clinical parameters, that underpin the basis for individual variation \-- variation that may ultimately be critical for understanding microbiome-based disorders. Clinical studies of the microbiome will be able to leverage the resulting extensive catalogs of taxa, pathways, and genes^[@R1]^, although they must also still include carefully matched internal controls. The uniqueness of each individual's microbiome even in this reference population argues for future studies to consider prospective within-subjects designs where possible. The HMP's unique combination of organismal and functional data across body habitats, encompassing both 16S and metagenomic profiling, together with detailed characterization of each subject, has allowed us and subsequent studies to move beyond the observation of variability in the human microbiome to ask how and why these microbial communities vary so extensively.

Many details remain for further work to fill in, building on this reference study. How do early colonization and life-long change vary among body habitats? Do epidemiological patterns of transmission of beneficial or harmless microbes mirror patterns of transmission of pathogens? Which co-occurrences among microbes reflect shared response to the environment, as opposed to competitive or mutualistic interactions? How large a role does host immunity or genetics play in shaping patterns of diversity, and how do the patterns observed in this North American population compare to those around the world? Future studies building on the gene and organism catalogs established by the Human Microbiome Project, including increasingly detailed investigations of metatranscriptomes and metaproteomes, will help to unravel these open questions and allow us to more fully understand the links between the human microbiome, health, and disease.

Methods Summary {#S6}
===============

Microbiome samples were collected from up to 18 body sites at one or two time points from 242 individuals clinically screened for absence of disease^[@R2]^. Samples were subjected to 16S rRNA gene pyrosequencing (454 Life Sciences), and a subset were shotgun sequenced for metagenomics using the Illumina GAIIx platform^[@R1]^. 16S data processing and diversity estimates were performed using QIIME^[@R27]^, and metagenomic data were taxonomically profiled using MetaPhlAn^[@R13]^, metabolically profiled by HUMAnN^[@R26]^, and assembled for gene annotation and clustering into a unique catalog^[@R1]^. Potential pathogens were identified using the PATRIC database^[@R14]^, isolate reference genome annotations drawn from KEGG^[@R28]^, and reference genome mapping performed by BWA^[@R29]^ to a reduced set of genomes to which short reads could be matched^[@R30]^. Microbial associations were assessed by similarity measures accounting for compositionality^[@R23]^, and phenotypic association testing was performed in R. All data and additional protocol details are available at <http://hmpdacc.org>. Full methods accompany this paper.
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16S data analysis: KMA, EJA, GLA, CAA, MB, BWB, JPB, GAB, SRC, SC, JC, TZD, FED, ED, AME, RCE, MF, AAF, JF, HG, DG, BJH, TAH, SMH, CH, JI, JKJ, STK, SKH, RK, HHK, OK, PSLR, REL, KL, CAL, DM, BAM, KAM, MM, MP, JFP, MP, KSP, XQ, KPR, MCR, BR, PDS, TMS, NS, JAS, WDS, TJS, CSS, EJS, RMT, JV, TAV, ZW, DVW, GMW, JRW, KMW, YY, SY, YZ

Shotgun data processing and alignments: CJB, JCC, ED, DG, AG, MEH, HJ, DK, KCK, CLK, YL, JCM, BAM, MM, DMM, JO, JFP, XQ, JGR, RKS, NUS, IS, EJS, GGS, SMS, JW, ZW, GMW, OW, KCW, TW, SKY, LZ

Assembly: HMA, CJB, PSC, LC, YD, SPD, MGF, MEH, HJ, SK, BL, YL, CL, JCM, JMM, JRM, PJM, MM, JFP, MP, MEP, XQ, MR, RKS, MS, DDS, GGS, SMS, CMT, TJT, WW, GMW, KCW, LY, YY, SKY, LZ

Annotation: OOA, VB, CJB, IAC, ATC, KC, HHC, ASD, MGG, JMG, JG, AG, SG, BJH, KH, SKH, CH, HJ, NCK, RM, VMM, KM, TM, MM, JO, KP, MP, XQ, NS, EJS, GGS, SMS, MT, GMW, KCW, JRW, CY, SKY, QZ, LZ

WGS Metabolic Reconstruction: SA, BLC, JG, CH, JI, BAM, MM, BR, AMS, NS, MT, GMW, SY, QZ, JDZ
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![Diversity of the human microbiome is concordant among measures, unique to each individual, and strongly determined by microbial habitat\
A) Alpha diversity within subjects by body habitat, as measured using the relative inverse Simpson index of 16S rRNA gene OTUs (red), genus-level phylotypes (blue), shotgun metagenomic reads matched to reference genomes (green), functional modules (yellow), and enzyme families (white). The mouth generally shows high within-subject diversity and the vagina low diversity, with other habitats intermediate; variation among individuals often exceeds variation among body habitats. B) Bray-Curtis beta diversity among subjects by body habitat, colors as for A. Skin differs most between subjects, with oral habitats and vaginal genera more stable. Although alpha- and beta-diversity are not directly comparable, changes in structure among communities (A) occupy a wider dynamic range than do changes within communities among individuals (B). C) Principal coordinates plot showing variation among samples demonstrates that primary clustering is by body area, with the oral, gastrointestinal, skin, and urogenital habitats separate; the nares bridge oral and skin habitats. D) Repeated samples from the same subject (red) are more similar than microbiomes from different subjects (yellow). Technical replicates (green) are in turn more similar; these patterns are consistent for all body habitats and for both phylogenetic and metabolic community composition. See previously described sample counts^[@R1]^ for all comparisons.](nihms378076f1){#F1}

![Carriage of microbial taxa varies while metabolic pathways remain stable within a healthy population\
Vertical bars represent microbiome samples by body habitat in the seven locations with both shotgun and 16S data; bars indicate relative abundances colored by A) microbial phyla from binned OTUs and B) metabolic modules. Legend indicates most abundant phyla/pathways by average within one or more body habitats; RC = retroauricular crease. A plurality of most communities' memberships consists of a single dominant phylum (and often genus; see [Supp. Fig. 2](#SD1){ref-type="supplementary-material"}), but this is universal neither to all body habitats nor to all individuals. Conversely, most metabolic pathways are evenly distributed and prevalent across both individuals and body habitats.](nihms378076f2){#F2}

![Abundant taxa in the human microbiome, which has been metagenomically and taxonomically well-defined in the HMP population\
A--C) Prevalence (intensity, color denoting phylum/class) and abundance when present (size) of clades in the healthy microbiome. The most abundant A) metagenomically-identified species, B) 16S-identified genera, and C) PATRIC^[@R14]^ "pathogens" (metagenomic). The population size and sequencing depths of the HMP have well-defined the microbiome at all assayed body sites, as assessed by saturation of added community D) metabolic configurations (rarefaction of minimum Bray-Curtis β-diversity of metagenomic EC abundances to nearest neighbor, inter-quartile range over 100 samples) and E) phylogenetic configurations (min. 16S OTU weighted UniFrac distance to nearest neighbor).](nihms378076f3){#F3}

![Microbial carriage varies between subjects down to the species and strain level\
Metagenomic reads from 127 tongue samples spanning 90 subjects were processed with MetaPhlAn to determine relative abundances for each species. A) Relative abundances of 11 distinct *Streptococcus* spp. In addition to variation in broader clades (see [Fig. 2](#F2){ref-type="fig"}), individual species within a single habitat demonstrate a wide range of compositional variation. Inset illustrates average tongue sample composition. B) Metabolic modules present/absent (grey/white) in KEGG^[@R28]^ reference genomes of tongue streptococci denote selected areas of strain-specific functional differentiation. C) Comparative genomic coverage for the single *Streptococcus mitis* B6 strain. Grey dots are median Reads Per Kilobase per Million reads (RPKM) for 1kb windows, gray bars are the 25th to 75th percentiles across all samples, red line the lowess smoothed average. Red bars at the bottom highlight predicted genomic islands^[@R31]^. Large, discrete, and highly variable islands are commonly under-represented. D) Two islands highlighted, V = V-type H+ ATPase subunits I,K,E,C,F,A & B, and CH = Choline binding proteins cbp6 and cbp12, indicating functional cohesion of strain-specific gene loss within individual human hosts.](nihms378076f4){#F4}

![Microbial community membership and function correlates with host phenotype and sample metadata\
The pathway and clade abundances most significantly associated (all FDR q\<0.2) using a multivariate linear model with A) subject race or ethnicity, B) vaginal posterior fornix pH, C) subject age, and D) BMI. Samples' scatter plots are shown with lines indicating best simple linear fit. Race/ethnicity and vaginal pH are particularly strong associations; age and BMI are more representative of typically modest phenotypic associations ([Sup. Table 3](#SD5){ref-type="supplementary-material"}), suggesting that variation in the healthy microbiota may correspond to other host or environmental factors.](nihms378076f5){#F5}
